P53 and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma

26Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Objective: The aim of this study was to determine by immunohistochemistry the presence and significance of p53 and bcl-2 proteins in oral lichen planus (OLP) and oral squamous cell carcinoma (OSCC). Study Design: We used 21 cases diagnosed as OLP 16 diagnosed as OSCC and four normal gingival biopsies taken from healthy patients were used as controls. Slides were processed for immunohistochemistry using anti-p53 and anti-bcl-2 monoclonal antibodies. Results: We found p53 immunoexpression in 71.4%OLP cases and 68.7%OSCC cases, with no immunoexpres-:immunoexpres- 71.4%% 688.7%% immunoexpression in control cases. Bcl-2 was negative for all OLP and OSCC cases, and mild positivity was observed in normal tissue. We found significant correlation among p53 expression and OSCC malignancy. Conclusions: Our results suggest that TP53 system mainly promotes a hyperproliferative state by cell cycle arrest of the OLP epithelial cells for repairing damaged DNA nor apoptosis and that anti-apoptotic action of bcl-2 is not important in this disease. © Medicina Oral S. L.

Cite

CITATION STYLE

APA

Leyva-Huerta, E. R., Ledesma-Montes, C., Rojo-Botello, R. E., & Vega-Memije, E. (2012). P53 and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma. Medicina Oral, Patologia Oral y Cirugia Bucal, 17(5). https://doi.org/10.4317/medoral.18013

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free